Proliferation of adult human bronchial epithelial cells without a telomere maintenance mechanism for over 200 population doublings.
ROCK inhibitor
conditional reprogramming
low oxygen
senescence
telomerase
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
18
09
2019
revised:
17
10
2019
accepted:
21
10
2019
entrez:
10
1
2020
pubmed:
10
1
2020
medline:
9
7
2020
Statut:
ppublish
Résumé
To date, there is no direct evidence of telomerase activity in adult lung epithelial cells, but typical culture conditions only support cell proliferation for 30-40 population doublings (PD), a point at which telomeres remain relatively long. Here we report that in in vitro low stress culture conditions consisting of a fibroblast feeder layer, rho-associated coiled coil protein kinase inhibitor (ROCKi), and low oxygen (2%), normal human bronchial epithelial basal progenitor cells (HBECs) divide for over 200 PD without engaging a telomere maintenance mechanism (almost four times the "Hayflick limit"). HBECs exhibit critically short telomeres at 200 PD and the population of cells start to undergo replicative senescence. Subcloning these late passage cells to clonal density, to mimic lung injury in vivo, selects for rare subsets of HBECs that activate low levels of telomerase activity to maintain short telomeres. CRISPR/Cas9 knockout of human telomerase reverse transcriptase or treatment with the telomerase-mediated telomere targeting agent 6-thio-2'deoxyguanosine abrogates colony growth in these late passage cultures (>200 PD) but not in early passage cultures (<200 PD). To our knowledge, this is the first study to report such long-term growth of HBECs without a telomere maintenance mechanism. This report also provides direct evidence of telomerase activation in HBECs near senescence when telomeres are critically short. This novel cell culture system provides an experimental model to understand how telomerase is regulated in normal adult tissues.
Identifiants
pubmed: 31914653
doi: 10.1096/fj.201902376R
pmc: PMC6956733
mid: NIHMS1057811
doi:
Substances chimiques
TERT protein, human
EC 2.7.7.49
Telomerase
EC 2.7.7.49
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
386-398Subventions
Organisme : NCI NIH HHS
ID : P50 CA070907
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA124334
Pays : United States
Organisme : HHS | NIH | National Cancer Institute (NCI)
ID : CA142543
Pays : International
Informations de copyright
© 2019 Federation of American Societies for Experimental Biology.
Références
Sci Rep. 2017 Jul 28;7(1):6785
pubmed: 28754961
EMBO Rep. 2018 Jan;19(1):73-88
pubmed: 29217659
J Cell Mol Med. 2011 Jun;15(6):1239-53
pubmed: 21251211
Am J Pathol. 2012 Feb;180(2):599-607
pubmed: 22189618
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
pubmed: 7568133
Biotechniques. 2016 Jun 01;60(6):306-9
pubmed: 27286808
N Engl J Med. 2007 Mar 29;356(13):1317-26
pubmed: 17392301
Science. 1995 Sep 1;269(5228):1236-41
pubmed: 7544491
Nature. 1990 May 31;345(6274):458-60
pubmed: 2342578
Nat Biotechnol. 1998 May;16(5):396-7
pubmed: 9592374
Mol Cell. 2004 May 21;14(4):501-13
pubmed: 15149599
Nat Rev Cancer. 2015 Jul;15(7):397-408
pubmed: 26105537
Nat Cell Biol. 2003 Aug;5(8):741-7
pubmed: 12855956
Am J Physiol Lung Cell Mol Physiol. 2003 May;284(5):L844-54
pubmed: 12676769
Int J Oncol. 1996 Sep;9(3):453-8
pubmed: 21541534
Am J Physiol Lung Cell Mol Physiol. 2009 Jan;296(1):L82-91
pubmed: 18978040
J Cell Biol. 2014 May 12;205(3):289-99
pubmed: 24821837
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6476-81
pubmed: 8692840
Nucleic Acids Res. 2014 Jul;42(13):e104
pubmed: 24861623
Nat Rev Genet. 2012 Oct;13(10):693-704
pubmed: 22965356
J Immunol. 1995 Oct 15;155(8):3711-5
pubmed: 7561072
Oncogene. 1996 Jul 18;13(2):433-9
pubmed: 8710384
J Invest Dermatol. 1997 Jan;108(1):113-7
pubmed: 8980299
PLoS Biol. 2016 Dec 15;14(12):e2000016
pubmed: 27977688
Cell Stem Cell. 2010 Aug 6;7(2):150-61
pubmed: 20682444
Dev Genet. 1996;18(2):173-9
pubmed: 8934879
Science. 1998 Jan 16;279(5349):349-52
pubmed: 9454332
Aging Cell. 2003 Oct;2(5):235-43
pubmed: 14570231
Blood. 1995 May 1;85(9):2315-20
pubmed: 7727765
Gastroenterology. 2010 Mar;138(3):1012-21.e1-5
pubmed: 19962984
Nature. 2015 Jan 29;517(7536):616-20
pubmed: 25383540
Am J Physiol Lung Cell Mol Physiol. 2018 Aug 1;315(2):L313-L327
pubmed: 29722564
Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L231-4
pubmed: 18487354
Nature. 2015 Jan 29;517(7536):621-5
pubmed: 25533958
Genes Dev. 2005 Sep 15;19(18):2100-10
pubmed: 16166375
Cell. 2007 May 4;129(3):523-36
pubmed: 17482546
Exp Cell Res. 1965 Mar;37:614-36
pubmed: 14315085
J Biol Chem. 2001 Aug 24;276(34):32198-203
pubmed: 11395519
Nat Biotechnol. 2009 Dec;27(12):1181-5
pubmed: 19935656
Nat Genet. 2015 May;47(5):512-7
pubmed: 25848748
Cancer Discov. 2015 Jan;5(1):82-95
pubmed: 25516420
Nature. 1989 Jan 26;337(6205):331-7
pubmed: 2463488
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9082-6
pubmed: 7568077
J Clin Invest. 2013 Mar;123(3):996-1002
pubmed: 23454763
Cancer Res. 2004 Dec 15;64(24):9027-34
pubmed: 15604268
Nat Commun. 2017 Nov 7;8(1):1356
pubmed: 29116081
Mayo Clin Proc. 2014 Aug;89(8):1130-42
pubmed: 24867394
Cell. 2000 Aug 18;102(4):407-10
pubmed: 10966103
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Science. 2005 Aug 19;309(5738):1253-6
pubmed: 16037417
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13051-6
pubmed: 18753630
Cancer J. 2001 Nov-Dec;7 Suppl 2:S83-93
pubmed: 11777269
Science. 1997 Aug 15;277(5328):955-9
pubmed: 9252327
Exp Cell Res. 1961 Dec;25:585-621
pubmed: 13905658
Mol Biol Cell. 2004 Aug;15(8):3709-18
pubmed: 15181152